全文获取类型
收费全文 | 10682篇 |
免费 | 995篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 114篇 |
儿科学 | 313篇 |
妇产科学 | 187篇 |
基础医学 | 1302篇 |
口腔科学 | 192篇 |
临床医学 | 1344篇 |
内科学 | 2268篇 |
皮肤病学 | 139篇 |
神经病学 | 1217篇 |
特种医学 | 387篇 |
外科学 | 1319篇 |
综合类 | 136篇 |
一般理论 | 15篇 |
预防医学 | 1260篇 |
眼科学 | 315篇 |
药学 | 685篇 |
中国医学 | 4篇 |
肿瘤学 | 504篇 |
出版年
2023年 | 56篇 |
2022年 | 85篇 |
2021年 | 272篇 |
2020年 | 165篇 |
2019年 | 236篇 |
2018年 | 273篇 |
2017年 | 226篇 |
2016年 | 194篇 |
2015年 | 223篇 |
2014年 | 278篇 |
2013年 | 459篇 |
2012年 | 612篇 |
2011年 | 690篇 |
2010年 | 329篇 |
2009年 | 302篇 |
2008年 | 505篇 |
2007年 | 560篇 |
2006年 | 558篇 |
2005年 | 506篇 |
2004年 | 488篇 |
2003年 | 447篇 |
2002年 | 442篇 |
2001年 | 269篇 |
2000年 | 278篇 |
1999年 | 225篇 |
1998年 | 99篇 |
1997年 | 82篇 |
1996年 | 70篇 |
1995年 | 75篇 |
1994年 | 64篇 |
1993年 | 76篇 |
1992年 | 175篇 |
1991年 | 174篇 |
1990年 | 182篇 |
1989年 | 154篇 |
1988年 | 166篇 |
1987年 | 150篇 |
1986年 | 150篇 |
1985年 | 131篇 |
1984年 | 93篇 |
1983年 | 95篇 |
1982年 | 77篇 |
1979年 | 63篇 |
1978年 | 78篇 |
1977年 | 71篇 |
1976年 | 59篇 |
1974年 | 62篇 |
1973年 | 62篇 |
1972年 | 53篇 |
1971年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Interaction effects between the 5‐hydroxy tryptamine transporter‐linked polymorphic region (5‐HTTLPR) genotype and family conflict on adolescent alcohol use and misuse
下载免费PDF全文
![点击此处可从《Addiction (Abingdon, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
5.
6.
Despite the widespread use of botulinum toxin to treat muscle dystonias, no method exists to quantify muscle paralysis in either human or nonhuman models. In this study we examined how the location, dose, and volume of botulinum injection affects paralysis in the rat tibialis anterior muscle. Paralysis was quantified by electrically stimulating the nerve to the tibialis anterior and then staining sections of the muscle for glycogen. The areas of glycogen-containing fibers represented regions of botulinum action. The results showed that the most important injection technique is to inject botulinum directly into the motor endplate region of a muscle. Injections only 0.5 cm from the motor endplate resulted in a 50% decrease in paralysis. Increases in dose increased paralysis, however, some of that increase was simply due to the increased volume of injection. Thus, delivering toxin in small volumes near the MEP band of a muscle should produce the most effectiveparalysis. © 1993 John Wiley & Sons, Inc. 相似文献
7.
Nafarelin controlled release injectable (CRI) releases a decapeptide drug for target one month therapy. Nafarelin, a luteinizing hormone releasing hormone agonistic analogue, is microencapsulated in biodegradable poly(lactide-co-glycolide) microspheres and given by intramuscular injection. Clinical data from a human single dose Phase I clinical study are modelled to develop theoretical multiple dose profiles and theoretical single dose profiles from mixtures of two or three formulations. Single dose injections of nafarelin CRI microspheres (4 mg nafarelin) containing 2, 4, or 7 per cent nafarelin all achieve useful plasma drug levels throughout the target 30 day interval. Therapeutic suppression of testosterone levels was observed in all subjects participating in the phase I clinical study. Highest plasma nafarelin levels are achieved in the 0-10 and 20-35 day post-injection intervals. Theoretical multiple dosing profiles generated from the single dose clinical results show significant oscillations in plasma nafarelin levels depending on the particular dosing interval selected. Thirty or forty day dosing intervals yield significant variability in plasma nafarelin levels at steady state; 15 day dosing intervals show less variability. Therapeutic testosterone suppression was observed in the single dose study, so the nafarelin dose per injection can be reduced in multiple dosing therapies. Theoretical plasma nafarelin profiles from certain mixtures of 2 and 4 per cent nafarelin microspheres or 2 and 7 per cent nafarelin microspheres indicate that a 60 day product could be achieved. In general, all three formulations yield their lowest plasma drug levels during the 10-20 day post-injection interval. Therefore any mixture of these formulations will likewise exhibit low plasma drug levels during this interval. 相似文献
8.
9.
Katherine A Hillman Tanya M Johnson Paul J D Winyard Geoffrey Burnstock Robert J Unwin Adrian S Woolf 《Experimental nephrology》2002,10(1):34-42
BACKGROUND: Purinergic receptors are cell-surface molecules that bind extracellular nucleotides, notably ATP. The P2X family includes seven nonselective ion channels with one member, P2X(7), implicated in cytolytic pore formation and cell death. MATERIALS AND METHODS: We sought P2X(7) expression in mouse nephrogenesis and cpk/cpk renal cyst growth, conditions in which both proliferation and apoptosis are prominent. RESULTS: P2X(7) immunolocalized to condensed metanephric mesenchyme: both proliferation and apoptosis were detected in this compartment, assessed by proliferating cell nuclear antigen expression and propidium iodide-stained pyknotic nuclei respectively. Later in nephrogenesis, P2X(7) was detected in collecting ducts, a pattern persisting to maturity. A mesenchymal to epithelial shift of P2X(7) expression was also documented in ureter development. In cpk/cpk kidneys, P2X(7)-expressing collecting duct cysts dominated histology from two weeks until four weeks after birth, when animals die from uremia. In polycystic kidneys pyknotic nuclei were rarely identified in P2X(7)-expressing epithelia, but were detected between cysts, consistent with a non-apoptotic role for P2X(7) in cyst enlargement. CONCLUSION: P2X(7) is expressed during normal nephrogenesis and in a model of congenital polycystic kidney disease. Further experiments are necessary to define possible functions of P2X(7) in these settings. 相似文献
10.
Fractures of the calcaneus generally occur in the event of high-energy trauma, resulting in complex, three-dimensionally oriented fracture patterns. Surgical management is generally indicated for displaced intra-articular fractures, which allows restoration of calcaneal height, width and overall morphology, in addition to the posterior facet articular surface where possible, and allows for a late in situ arthrodesis as a means of salvage in the event of posttraumatic arthritis. What follows is a brief discussion of our preferred methods in the diagnosis and management of calcaneal fractures. 相似文献